Skip to main navigation Skip to search Skip to main content

CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Aggressive pediatric brain tumor models of ependymoma are highly sensitive to GD2-directed (CAR T) cell therapy.

Original languageEnglish
JournalThe Journal of clinical investigation
Volume136
Issue number2
DOIs
Publication statusPublished - 16 Jan 2026

Keywords

  • Brain cancer
  • Cancer immunotherapy
  • Immunology
  • Neuroscience
  • Oncology

Fingerprint

Dive into the research topics of 'CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models'. Together they form a unique fingerprint.

Cite this